Five year financial summary
| $000 except per share amounts |
2008 |
2009 |
2010 |
2011
|
2012 |
| Revenue from continuing operations - Note 1 |
78,022 |
86,075 |
76,803 |
75,872 |
79,834 |
| EBITDA |
18,721 |
22,070 |
16,316 |
14,784 |
16,194 |
| EBIT |
13,384 |
16,434 |
9,726 |
8,173 |
9,654 |
| Net profit from continuing operations |
7,925 |
10,133 |
6,196 |
582 |
6,010 |
| Net profit from discontinued operations - Note 2 |
(757) |
- |
- |
- |
- |
| Reported net profit after tax |
7,168 |
10,133 |
6,196 |
582 |
6,010 |
| Adjusted net profit after tax - Note 3 |
7,914 |
10,435 |
6,145 |
5,127 |
6,519 |
| |
|
|
|
|
|
| Adjusted earnings per share from continuing operations (cents) |
56 |
74 |
43 |
36 |
42 |
| Dividends per share (cents) |
20 |
25 |
18 |
15 |
17 |
| |
|
|
|
|
|
| Total assets |
110,752 |
124,196 |
126,947 |
123,526 |
173,041 |
| Total equity |
79,561 |
91,556 |
96,448 |
88,432 |
113,806 |
| Net tangible assets per share ($) |
4.10 |
4.86 |
5.14 |
4.62 |
5.29 |
| |
|
|
|
|
|
| Cash flows from operating activities |
12,934 |
19,245 |
12,584 |
11,868 |
12,135 |
| Capital expenditure - Note 4 |
4,135 |
6,507 |
9,434 |
17,594 |
15,929 |
1- 2008, 2009, 2010, 2011 and 2012 revenues are stated inclusive of the full value of ACC and DHB contracts, whereas 2007 revenues are shown net of payments to specialists under these contracts reflecting the accounting presentation that was applied at that time.
2- Represents the results of P3 Research Limited, which was sold in August 2007.
3- Adjusted net profit after tax excludes adjustments to deferred tax in the 2011 financial year for changes in tax legislation of $4.3m, revaluation of interest rate swaps (net of tax effect) and discontinued operations.
4- Represents payments for the purchase of property, plant and equipment plus payments for the purchase of software.
|
